Ultra‐Small High‐Entropy Alloy Nanoparticles: Efficient Nanozyme for Enhancing Tumor Photothermal Therapy
Advanced Materials · 2023-06 · 35 (23)
DOI: 10.1002/adma.202302335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 23.04.2023. Verfasst von Yongjian Ai und 7 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry, Laboratory of Flexible Electronics Technology, Cen…. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles. Die Arbeit wurde bisher 260-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Key R&D Program of China, Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine, Tsinghua-Foshan Innovation Special Fund.
Abstract (Originalsprache)
High‐entropy alloys nanoparticles (HEANPs) are receiving extensive attention due to their broad compositional tunability and unlimited potential in bioapplication. However, developing new methods to prepare ultra‐small high‐entropy alloy nanoparticles (US‐HEANPs) faces severe challenges owing to their intrinsic thermodynamic instability. Furthermore, there are few reports on studying the effect of HEANPs in tumor therapy. Herein, the fabricated PtPdRuRhIr US‐HEANPs act as bifunctional nanoplatforms for the highly efficient treatment of tumors. The US‐HEANPs are engineered by the universal metal‐ligand cross‐linking strategy. This simple and scalable strategy is based on the aldol condensation of organometallics to form the target US‐HEANPs. The synthesized US‐HEANPs exhibit excellent peroxidase‐like (POD‐like) activity and can catalyze the endogenous hydrogen peroxide to produce highly toxic hydroxyl radicals. Furthermore, the US‐HEANPs possess a high photothermal conversion effect for converting 808 nm near‐infrared light into heat energy. In vivo and in vitro experiments demonstrated that under the synergistic effect of POD‐like activity and photothermal action, the US‐HEANPs can effectively ablate cancer cells and treat tumors. It is believed that this work not only provides a new perspective for the fabrication of HEANPs, but also opens the high‐entropy nanozymes research direction and their biomedical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry, Laboratory of Flexible Electronics Technology, Center for Synthetic and Systems Biology, Tsinghua University-Peking Univ…
- Department of Chemistry, College of Science, Northeastern University, Shenyang, 110819, P. R. China.
ORCID-Profile: Qionglin Liang
Förderung
- National Key R&D Program of China
- Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
- Tsinghua-Foshan Innovation Special Fund
- Postdoctoral Innovative Talent Support Program
- China Postdoctoral Science Foundation Funded Project
- Innovation Zone Project
- National Natural Science Foundation of China
- Young Elite Scientist Sponsorship Program of the Beijing Association for Science and Technology
Zitieren
APA
Ai, Y., He, M. Q., Sun, H., Jia, X., Wu, L., Zhang, X., Sun, H. B., & Liang, Q. (2023). Ultra‐Small High‐Entropy Alloy Nanoparticles: Efficient Nanozyme for Enhancing Tumor Photothermal Therapy. Advanced Materials, 35(23). https://doi.org/10.1002/adma.202302335
Vancouver
Ai Y, He MQ, Sun H, Jia X, Wu L, Zhang X, et al. Ultra‐Small High‐Entropy Alloy Nanoparticles: Efficient Nanozyme for Enhancing Tumor Photothermal Therapy. Advanced Materials. 2023;35(23). doi:10.1002/adma.202302335
BibTeX
@article{Ai2023,
author = {Ai, Yongjian and He, Meng-Qi and Sun, Hua and Jia, Xiaomeng and Wu, Lei and Zhang, Xinyue and Sun, Hong-Bin and Liang, Qionglin},
title = {Ultra‐Small High‐Entropy Alloy Nanoparticles: Efficient Nanozyme for Enhancing Tumor Photothermal Therapy},
journal = {Advanced Materials},
year = {2023},
volume = {35},
number = {23},
doi = {10.1002/adma.202302335}
}
EUVIMED